| Cell line name |
A549/CPT |
|---|
| Accession |
CVCL_H268 |
|---|
| Resource Identification Initiative |
To cite this cell line use: A549/CPT (RRID:CVCL_H268) |
|---|
| Comments |
Population: Caucasian.
Selected for resistance to: ChEBI; CHEBI_27656; Camptothecin (CPT).
Derived from site: In situ; Lung; UBERON=UBERON_0002048. |
|---|
| Sequence variations |
- Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
|
|---|
| Disease |
Lung adenocarcinoma (NCIt: C3512) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Parent: CVCL_0023 (A-549) |
|---|
| Sex of cell |
Male |
|---|
| Age at sampling |
58Y |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=2170010
Sugimoto Y., Tsukahara S., Oh-hara T., Isoe T., Tsuruo T.
Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody.
Cancer Res. 50:6925-6930(1990) PubMed=2174738
Sugimoto Y., Tsukahara S., Oh-hara T., Liu L.F., Tsuruo T.
Elevated expression of DNA topoisomerase II in camptothecin-resistant human tumor cell lines.
Cancer Res. 50:7962-7965(1990) PubMed=14973057; DOI=10.1158/0008-5472.CAN-3263-2
Yasui K., Mihara S., Zhao C., Okamoto H., Saito-Ohara F., Tomida A., Funato T., Yokomizo A., Naito S., Imoto I., Tsuruo T., Inazawa J.
Alteration in copy numbers of genes as a mechanism for acquired drug resistance.
Cancer Res. 64:1403-1410(2004) |
|---|
| Cross-references |
|---|
| Cell line databases/resources |
cancercelllines; CVCL_H268
CGH-DB; 9107-4
|
|---|
| Encyclopedic resources |
Wikidata; Q54607045
|
|---|
| Entry history |
|---|
| Entry creation | 11-Feb-2013 |
|---|
| Last entry update | 19-Dec-2024 |
|---|
| Version number | 16 |
|---|
